Markets › United States › NAS › DMRA

Damora Therapeutics Inc

NAS:DMRAHealthcareCBOEFTSE:MRUTNASDAQ:NQUSSG

$20.58+6.80%LiveIn session · ≈ AED 75.58 · Market cap $1.27B · Next earnings Fri 30 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Return on equity	−21.1%	−44.1%	−99.8%	−118.6%	−148.2%	−87.3%	−87.3%	+0.0 pts
Return on assets	−20.3%	−42.3%	−84.2%	−100.3%	−125.1%	−80.5%	−80.5%	+0.0 pts
Return on capital employed	−20.3%	−44.4%	−98.6%	−112.5%	−106.0%	−87.7%	—	—
Debt / equity	0.0×	0.0×	0.0×	0.0×	0.1×	0.0×	0.0×	+0.0%
Debt / assets	0.5%	0.7%	1.1%	0.7%	8.4%	0.0%	—	—
Interest coverage	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Current ratio	30.4×	24.2×	5.8×	6.3×	14.1×	13.0×	13.0×	+0.0%
Quick ratio	30.4×	24.2×	5.8×	6.3×	14.1×	13.0×	—	—
Cash ratio	29.4×	13.8×	3.0×	3.7×	11.8×	12.8×	12.8×	+0.0%
Asset turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Receivables turnover	0.0×	0.0×	0.0×	0.0×	0.0×	0.0×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—